Effects of anti-inflammatory dietary supplements on pelvic pain in females with endometriosis: A GRADE-assessed systematic review and meta-analysis of RCTs

meta-analysis OA: bronze public-domain-us
AI-generated deep summary by claude@2026-06, 2026-06-14 · read from full text

This paper is a GRADE-assessed systematic review and meta-analysis of randomized controlled trials evaluating anti-inflammatory dietary supplements for pelvic pain in adult females with endometriosis, searching PubMed, Scopus, and Web of Science up to December 2023. Using random-effects meta-analysis and Cochrane risk-of-bias assessment, the authors found a significant reduction in pelvic pain after supplementation, with subgroup effects varying by age (≥32 years), supplementation duration (>8 weeks), intervention type (anti-inflammatory vitamins), endometriosis stage (>II), and baseline BMI (>23 kg/m2). The paper also evaluated certainty of evidence with GRADE, and its conclusions are limited to the available RCT evidence included in the review. This paper is centrally about endometriosis — it focuses specifically on anti-inflammatory dietary supplements and their effects on pelvic pain in people with endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND: Endometriosis, the most perplexing gynecologic condition, impairs the quality of life because it is usually accompanied by persistent severe acyclic pelvic pain and infertility as its two main symptoms. The majority economic burden of endometriosis is due to infertility and pelvic pain. Therefore, alleviating pelvic pain in patients with endometriosis is a necessity. OBJECTIVES: The present systematic review and meta-analysis aimed to summarize evidence about the effects of anti-inflammatory dietary supplements on pelvic pain in females with endometriosis. SEARCH STRATEGY: PubMed, Scopus, and Web of Science as online databases were systematically searched by relevant keywords up to December 2023. SELECTION CRITERIA: Randomized controlled clinical trials (RCTs) with either a parallel or crossover design conducted in adults with endometriosis were selected. DATA COLLECTION AND ANALYSIS: Random effect analysis was used to run meta-analysis. Subgroup analyses were run to detect heterogeneity sources. Quality assessment was done by revised Cochrane Collaboration tool II. The certainty of evidence was evaluated by the GRADE tool. MAIN RESULTS: A significant decrease in pelvic pain following supplementation with anti-inflammatory dietary supplements was detected. Also, anti-inflammatory dietary supplements could significantly decline pelvic pain in patients with endometriosis when the age of the participants was ≥32 years, the duration of supplementation was >8 weeks, the type of intervention was anti-inflammatory vitamins, the stage of endometriosis of study participants was > II, and baseline body mass index (BMI) of the participants was >23 kg/m2. CONCLUSIONS: Use of anti-inflammatory dietary supplements in females with endometriosis results in a remarkable decrease in pelvic pain.
Full text 2,263 characters · extracted from oa-html · 3 sections · click to expand

Abstract

Background Endometriosis, the most perplexing gynecologic condition, impairs the quality of life because it is usually accompanied by persistent severe acyclic pelvic pain and infertility as its two main symptoms. The majority economic burden of endometriosis is due to infertility and pelvic pain. Therefore, alleviating pelvic pain in patients with endometriosis is a necessity.

Objectives

The present systematic review and meta-analysis aimed to summarize evidence about the effects of anti-inflammatory dietary supplements on pelvic pain in females with endometriosis. Search Strategy PubMed, Scopus, and Web of Science as online databases were systematically searched by relevant keywords up to December 2023. Selection Criteria Randomized controlled clinical trials (RCTs) with either a parallel or crossover design conducted in adults with endometriosis were selected. Data Collection and Analysis Random effect analysis was used to run meta-analysis. Subgroup analyses were run to detect heterogeneity sources. Quality assessment was done by revised Cochrane Collaboration tool II. The certainty of evidence was evaluated by the GRADE tool. Main Results A significant decrease in pelvic pain following supplementation with anti-inflammatory dietary supplements was detected. Also, anti-inflammatory dietary supplements could significantly decline pelvic pain in patients with endometriosis when the age of the participants was ≥32 years, the duration of supplementation was >8 weeks, the type of intervention was anti-inflammatory vitamins, the stage of endometriosis of study participants was > II, and baseline body mass index (BMI) of the participants was >23 kg/m2.

Conclusions

Use of anti-inflammatory dietary supplements in females with endometriosis results in a remarkable decrease in pelvic pain. CONFLICT OF INTEREST STATEMENT All authors declare no conflict of interest. DATA AVAILABILITY STATEMENT The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosischronic_pelvic_paininfertility

MeSH descriptors

Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents Anti-Inflammatory Agents

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-08-09T06:10:49.860119+00:00
pubmed
last seen: 2026-08-09T06:08:14.424960+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine